Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2003
10/02/2003WO2003080809A2 Methods and compositions for using zinc finger endonucleases to enhance homologous recombination
10/02/2003WO2003080808A2 Novel compositions and methods in cancer
10/02/2003WO2003080807A2 Compositions and methods for suppressing eukaryotic gene expression
10/02/2003WO2003080805A2 Kinases and phosphatases
10/02/2003WO2003080802A2 Nucleic acid constructs and methods for producing altered seed oil compositions
10/02/2003WO2003080794A2 Inhibition of rna function by delivery of inhibitors to animal cells
10/02/2003WO2003080673A1 Costimulatory molecule and its use
10/02/2003WO2003080668A1 NUCLEAR RECEPTOR RXRα ISOFORMS
10/02/2003WO2003080667A2 A novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
10/02/2003WO2003080666A2 An adipocyte insulin and a method of treating diabetes
10/02/2003WO2003080665A2 Antibody that binds to a dimer of a prion protein for the treatment of tse infection
10/02/2003WO2003080664A1 P-rex1, a ptdins (3, 4, 5) p3- g-beta-gamma-regulated guanine-nucleotide exchange factor for rac
10/02/2003WO2003080663A2 Tenascin-w compositions and uses thereof
10/02/2003WO2003080662A1 Protein kinase c modulators, their aminoacid and nucleotide sequences and uses thereof
10/02/2003WO2003080661A1 Diagnostic and therapeutic use of human maguin proteins and nucleic acids for neurodegenerative diseases
10/02/2003WO2003080660A2 Method for the preparation of recombinant mammalian heparin-binding protein (hbp)
10/02/2003WO2003080657A2 Yeast pheromones for the treatment of infectious diseases
10/02/2003WO2003080655A1 A mutated immunoglobulin-binding protein
10/02/2003WO2003080654A2 Helicobacter flagellar, motility polypeptides
10/02/2003WO2003080648A2 Raav vector compositions and methods for the treatment of choroidal neovascularization
10/02/2003WO2003080647A2 Homogentisate prenyl transferase ('hpt') nucleic acids and polypeptides, and uses thereof
10/02/2003WO2003080645A2 Amplification of nucleic acid fragments using nicking agents
10/02/2003WO2003080640A1 Lymphatic and blood endothelial cell genes
10/02/2003WO2003080639A1 Novel compositions and methods in cancer associated with altered expression of kcnj9
10/02/2003WO2003080638A2 Antisense iap nucleobase oligomers and uses thereof
10/02/2003WO2003080570A2 Recombinant expression vectors for functional nav1.9 sodium channels
10/02/2003WO2003080569A2 Egfr ligands and methods of use
10/02/2003WO2003080209A2 Method of concentrating macromolecules or agglomerates of molecules or particles
10/02/2003WO2003080122A1 Method and agent for producing therapeutically active blood compositions
10/02/2003WO2003080112A2 Imidazoquinolineamines as adjuvants in hiv dna vaccination
10/02/2003WO2003080105A2 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof
10/02/2003WO2003080083A1 Use of adenoviruses mutated in the va genes for cancer treatment
10/02/2003WO2003079995A2 Neisseria mutants, lipooligosaccharides and immunogenic compositions
10/02/2003WO2003079977A2 Novel compositions and methods in cancer associated with altered expression of mcm3ap
10/02/2003WO2003079967A2 Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue
10/02/2003WO2003079883A2 Controlled laser treatment for non-invasive tissue alteration, treatment and diagnostics with minimal collateral damage
10/02/2003WO2003079776A2 Identification of the flt1 gene required for angiogenesis in zebrafish, and uses thereof
10/02/2003WO2003079769A1 Functional plant, promoter to be used for producing the functional plant and method of using the same
10/02/2003WO2003079767A1 Method of transforming plant of the genus coffer
10/02/2003WO2003079766A2 Generation of plants with altered oil content
10/02/2003WO2003079765A2 Refined plant transformation
10/02/2003WO2003079757A2 Hiv therapeutic
10/02/2003WO2003079750A2 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF
10/02/2003WO2003064441A3 Oligonucleotides comprising alternating segments and uses thereof
10/02/2003WO2003062414A3 Methods of obtaining isoform specific expression in mammalian cells
10/02/2003WO2003062394A9 Methods and compositions for rna interference
10/02/2003WO2003056011A3 Therapeuticum and prophylacticum for malignant diseases using phenotype suppression
10/02/2003WO2003054154A3 Antisense modulation of mucin 1, transmembrane expression
10/02/2003WO2003052133A3 Oligonucleotide analogues comprising intercalator pseudonucleotides
10/02/2003WO2003046180A3 Human cdnas and proteins and uses thereof
10/02/2003WO2003035694A3 Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof
10/02/2003WO2003033713A8 Production of oil with higher erucic acid content
10/02/2003WO2003033534A3 Ngzipa, ngzipd, pgzipa, and pgzipd polynucleotides and polypeptides and uses thereof
10/02/2003WO2003024991A3 Tall-1 receptor molecules and uses thereof
10/02/2003WO2003020938A3 Method of protein production in plants
10/02/2003WO2003020767A3 Antibodies against caspase-8, their preparation and use
10/02/2003WO2003016535A3 Novel amylases and uses thereof
10/02/2003WO2003015505A3 An animal model exhibiting cancer, pulmonary emphysema and cardiomyopathy
10/02/2003WO2003013593A3 Composite superimmunogen for bi-functional vaccine use for the treatment of illnesses associated with a stromal tissue disorder
10/02/2003WO2003011906A3 Use of peptide fragments of the calcium channel α-1 subunit, optionally comprising mutations, for screening molecules of therapeutic interest
10/02/2003WO2003010199A3 Identification of specific tumour antigens by means of the selection of cdna libraries with sera and the use of said antigens in diagnostic imaging techniques
10/02/2003WO2003010194A3 Meningococcus adhesins nada, app and orf 40
10/02/2003WO2003008556A3 A vector containing an enhanced p15a origin of replication
10/02/2003WO2003006950A3 Cells of the cardiomyocyte lineage produced from human pluripotent stem cells
10/02/2003WO2003006493A3 Histidine phosphatase interacting protein with 180kd
10/02/2003WO2003004655A3 Use of the cd24 marker gene for the selection of keratinocyte stem cells transformed by exogenous sequences
10/02/2003WO2003000893A3 Nucleic acids encoding g protein-coupled receptors
10/02/2003WO2002101015A3 Integrative assays for monitoring molecular assembly events
10/02/2003WO2002099056A3 C22c7orfs as modifiers of the p53 pathway and methods of use
10/02/2003WO2002097040A3 Methods for the identification of inhibitors of pectin esterase expression or activity in plants
10/02/2003WO2002092759A3 Molecules for disease detection and treatment
10/02/2003WO2002081712A3 Artificial chromosomes comprising ehv sequences
10/02/2003WO2002081691A9 Abcg5 and abcg8: compositions and methods of use
10/02/2003WO2002080852A3 Genes expressed in intestinal epithelium and peyer's patch m cells
10/02/2003WO2002079473A3 Molecules for diagnostics and therapeutics
10/02/2003WO2002079461A3 Type ii thioesterase from streptomyces coelicolor a3(2) and the coding sequence
10/02/2003WO2002077274A3 Methods for purifying and detecting double stranded dna target sequences by triple helix interaction
10/02/2003WO2002074323A3 Using neural thread proteins to treat tumors and other hyperproliferative disorders
10/02/2003WO2002070737A9 Compositions and methods relating to osteoarthritis
10/02/2003WO2002068597A3 Enzymes having alpha amylase activity and methods of use thereof
10/02/2003WO2002064794A3 Herbicide target genes and methods
10/02/2003WO2002063037A3 Method for identifying functional nucleic acids
10/02/2003WO2002061094A3 Microbiological method for producing l-carnitine
10/02/2003WO2002061037A3 Administration of nucleic acid sequence to female animal
10/02/2003WO2002059355A3 Polynucleotides for use as tags and tag complements, manufacture and use thereof
10/02/2003WO2002057474A3 Processes for enhanced production of pantothenate
10/02/2003WO2002057289A8 Reagent for the isolation of rna
10/02/2003WO2002053771A3 Detection of pathogenic bacteria
10/02/2003WO2002045497A3 Transgenic mice containing dusp8 phosphatase gene disruptions
10/02/2003WO2002044392A9 Dna encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5a, transgenic plants and a method for controlling senescence programmed and cell death in plants
10/02/2003WO2002044197A3 Cytokine receptor binding peptides
10/02/2003WO2002033104A3 Antibiotic-based gene regulation system
10/02/2003WO2002029104A3 Tumor marker and methods of use
10/02/2003WO2002022811A3 Modulation of meiotic recombination
10/02/2003WO2002022809A3 PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST
10/02/2003WO2002022573A3 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies
10/02/2003WO2002012551A3 Map-based genome mining method for identifying gene regulatory loci
10/02/2003WO2002006315A3 Novel nucleic acid and amino acid sequences
10/02/2003WO2002004948A3 Distinguishing molecular forms
10/02/2003WO2002002623A3 Compositions and methods for the therapy and diagnosis of lung cancer
1 ... 2407 2408 2409 2410 2411 2412 2413 2414 2415 2416 2417 2418 2419 2420 2421 2422 2423 2424 2425 2426 2427 ... 4023